1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Hemp Naturals, Inc.

Hemp Naturals, Inc.

HPMM
Hemp Naturals, Inc.US flagOther OTC
0.00
USD
- -
- -
34,926.00Market Cap
Hemp Naturals, Inc.
HPMM
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
TTM
FRC
- -
- -
- -
- -
- -
Revenue per Share
- -
-1.56
-52.76
-12.29
-12.39
Basic EPS, GAAP
- -
-0.46
-2.18
-0.39
-0.39
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
-2.11
-53.08
-19.83
-20
Book Value per Share
- -
1.96
49.28
11.97
12.07
Tangible Book Value per Share
- -
- -
- -
1
1
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-4
-6
-6
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
4
6
6
Working Capital
- -
- -
- -
- -
- -
LT Debt
- -
- -
4
6
6
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'18
Aug'18
Nov'18
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
42
63
79

Working Capital

FRC

•

in mil. unless spec.
May'18
Aug'18
Nov'18
Total Current Assets
12
11
7
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
70.55%
Free Cash Flow
- -
- -
26.06%
Net Income, GAAP
- -
- -
63.52%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
- -
-0.36
-0.43
- -
-1.56
2017
-2.8
-0.84
-0.85
- -
-52.76
2018
-2.35
-3.74
-3.4
- -
-12.29

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
Similar Companies
MPX International Corp. (MPXOF)
Boiron S.A. (BOIRF)
Ajanta Pharma Limited (AJANTPHARM.BO)
Merck KGaA (MRK.DE)
The Hash Corporation (REZN.CN)
Sweet Earth Holdings Corporation (SE.CN)
Business
Hemp Naturals, Inc. is an early-stage company engaged in researching, developing, acquiring, and selling products made from industrial hemp. The company primarily manufactures and distributes hemp-based rolling papers and has expanded its product range to include CBD hemp flower strains such as Pineapple Express and Fruity Pebbles. Its products are distributed through approximately 50 retail locations across Florida, including gas stations, convenience stores, tobacco shops, and liquor stores. Hemp Naturals operates cultivation facilities, including a recently acquired 117-acre private farm in Maine for outdoor high-CBD industrial hemp biomass cultivation, and a commercial production facility in upstate New York featuring advanced solar-enabled production capabilities. This expansion aligns with the company’s strategic positioning to benefit from evolving cannabis legalization and demand growth in the CBD market. Founded in 2018 and headquartered in Miami, Florida, the company targets both retail consumers and bulk industrial buyers in the hemp and CBD market segments. Recent major developments include the acquisition of farmland in Maine and the expansion of its product portfolio with ten new CBD hemp flower strains, reinforcing its growth strategy in anticipation of federal cannabis legalization and increased market penetration. Hemp Naturals, Inc. continues to focus on strengthening shareholder value through strategic acquisitions and product diversification within the industrial hemp sector.